Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 19 04:00PM ET
230.74
Dollar change
-1.00
Percentage change
-0.43
%
IndexS&P 500 P/E50.78 EPS (ttm)4.54 Insider Own0.14% Shs Outstand290.39M Perf Week0.71%
Market Cap66.69B Forward P/E16.18 EPS next Y14.26 Insider Trans-2.15% Shs Float288.61M Perf Month-1.28%
Income1.32B PEG5.90 EPS next Q3.31 Inst Own87.95% Short Float0.80% Perf Quarter-1.03%
Sales19.72B P/S3.38 EPS this Y6.82% Inst Trans-1.90% Short Ratio1.58 Perf Half Y-1.81%
Book/sh88.74 P/B2.60 EPS next Y9.33% ROA2.54% Short Interest2.32M Perf Year-9.48%
Cash/sh11.14 P/C20.70 EPS next 5Y8.60% ROE5.37% 52W Range218.75 - 287.32 Perf YTD-5.37%
Dividend Est.3.78 (1.64%) P/FCF22.04 EPS past 5Y52.43% ROI3.17% 52W High-19.69% Beta0.43
Dividend TTM3.76 (1.63%) Quick Ratio0.97 Sales past 5Y4.18% Gross Margin41.25% 52W Low5.48% ATR (14)4.60
Dividend Ex-DateJun 10, 2024 Current Ratio1.41 EPS Y/Y TTM-16.60% Oper. Margin12.43% RSI (14)50.12 Volatility2.25% 2.00%
Employees73000 Debt/Eq0.70 Sales Y/Y TTM4.82% Profit Margin6.68% Recom1.63 Target Price276.46
Option/ShortYes / Yes LT Debt/Eq0.62 EPS Q/Q20.61% Payout73.72% Rel Volume0.73 Prev Close231.74
Sales Surprise0.15% EPS Surprise6.77% Sales Q/Q4.65% EarningsAug 01 BMO Avg Volume1.47M Price230.74
SMA200.21% SMA50-0.89% SMA200-3.73% Trades Volume1,069,083 Change-0.43%
Date Action Analyst Rating Change Price Target Change
May-30-24Initiated Goldman Buy $274
Jul-24-23Upgrade Raymond James Mkt Perform → Outperform $305
May-30-23Resumed Morgan Stanley Overweight $295
May-05-23Upgrade Piper Sandler Neutral → Overweight $260 → $290
Apr-12-23Upgrade KeyBanc Capital Markets Sector Weight → Overweight $304
Jan-03-23Upgrade BofA Securities Neutral → Buy $250 → $290
Dec-12-22Upgrade Citigroup Sell → Neutral $221 → $250
Jul-11-22Downgrade Citigroup Neutral → Sell $265 → $235
Jun-24-22Upgrade Wells Fargo Equal Weight → Overweight $275
Mar-18-22Resumed Raymond James Mkt Perform
Jul-19-24 08:58AM
Jul-16-24 12:19PM
Jul-11-24 03:45PM
Jul-10-24 12:12PM
06:50AM
12:08PM Loading…
Jul-05-24 12:08PM
Jul-04-24 04:12AM
Jul-03-24 08:30AM
Jul-01-24 06:00AM
Jun-27-24 12:51PM
Jun-26-24 06:45AM
Jun-22-24 07:27AM
07:20AM
Jun-20-24 08:30AM
Jun-10-24 07:01AM
02:31PM Loading…
Jun-06-24 02:31PM
02:25PM
Jun-05-24 12:18PM
Jun-04-24 04:45AM
Jun-03-24 04:30PM
02:13PM
11:58AM
11:34AM
08:25AM
06:30AM
06:30AM
May-21-24 04:30PM
May-17-24 12:27PM
May-15-24 10:57AM
06:45AM
10:51AM Loading…
May-06-24 10:51AM
06:51AM
May-03-24 11:39AM
07:08AM
03:01AM
01:07AM
May-02-24 10:26PM
02:16PM
01:59PM
10:54AM
09:40AM
09:30AM
09:25AM
09:15AM
08:48AM
07:52AM
07:40AM
07:25AM
07:18AM
06:41AM
06:30AM
May-01-24 03:00PM
Apr-30-24 04:15PM
Apr-29-24 04:15PM
12:21PM
09:16AM
Apr-26-24 06:00AM
Apr-18-24 05:35AM
Apr-12-24 11:04AM
Apr-09-24 10:15AM
Apr-08-24 10:27AM
Apr-05-24 06:45AM
Apr-04-24 04:15PM
09:40AM
Apr-03-24 08:48PM
Apr-02-24 04:12PM
Mar-27-24 06:50AM
Mar-26-24 09:31AM
Mar-21-24 07:05AM
06:57AM
06:50AM
Mar-18-24 06:50AM
Mar-14-24 01:00PM
11:57AM
Mar-13-24 04:30PM
06:50AM
Mar-12-24 10:34AM
Mar-06-24 05:05AM
Mar-05-24 08:28AM
Mar-04-24 05:35PM
07:37AM
06:50AM
Feb-29-24 05:26AM
Feb-27-24 01:28PM
06:50AM
Feb-26-24 09:18AM
Feb-23-24 11:14AM
Feb-21-24 06:45AM
Feb-18-24 01:26PM
Feb-15-24 04:15PM
Feb-13-24 12:07PM
Feb-12-24 04:43PM
Feb-06-24 10:28AM
Feb-05-24 12:23AM
Feb-02-24 08:52AM
12:17AM
12:01AM
Feb-01-24 01:11PM
10:35AM
10:01AM
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Spoerel Thomas JSVP,Controller&Chief Acct OffJun 10 '24Sale239.3130071,7931,976Jun 11 01:45 PM
Goette RolandEVP and President EMEAMay 15 '24Sale236.733,300781,22411,308May 16 07:54 PM
Goette RolandEVP and President EMEAMay 13 '24Sale236.703,300781,12114,608May 15 02:44 PM
Garrison Michael DavidEVP & President MedicalApr 30 '24Sale232.811,715399,2695,381May 01 12:59 PM
Spoerel Thomas JSVP,Controller&Chief Acct OffMar 14 '24Sale238.2928267,1982,276Mar 15 02:19 PM
Garrison Michael DavidEVP & President MedicalDec 11 '23Sale232.461,239288,0187,274Dec 12 04:31 PM
Byrd RichardEVP & President InterventionalNov 28 '23Sale238.472,156514,1414,120Nov 29 07:27 PM
Goette RolandEVP and President, EMEANov 16 '23Option Exercise107.123,544379,63317,164Nov 20 02:20 PM
Byrd RichardEVP & President InterventionalSep 05 '23Sale274.48459125,9863,444Sep 06 09:32 AM
Fraser ClaireDirectorAug 28 '23Sale281.66848238,84821,608Aug 30 08:48 AM
Hickey DavidEVP & President, Life SciencesAug 11 '23Option Exercise132.543,883514,6539,030Aug 14 04:40 PM
Hickey DavidEVP & President, Life SciencesAug 11 '23Sale277.852,974826,3264,199Aug 14 04:40 PM
Garrison Michael DavidEVP & President MedicalAug 08 '23Sale277.131,300360,2695,157Aug 09 02:41 PM